Abstract
Objective
To describe a novel KAL1 mutation in patients affected by Kallmann syndrome.
Setting
Endocrinology Clinic of the João de Barros Barreto University Hospital – Federal University of Pará, Brazil.
Methods
Clinical examination, hormone assays and sequencing of exons 5, 6 and 9 of the KAL1 gene in four Brazilian brothers with Kallmann syndrome.
Results
Detected a novel KAL1 mutation, c.612G.A/p.Trp204*, in four hemizygous brothers with Kallmann syndrome, and five heterozygous female family members.
Conclusion
The novel p.Trp204* mutation of the KAL1 gene results in the production of a truncated anosmin-1 enzyme in patients with Kallmann syndrome. This finding broadens the spectrum of pathogenic mutations for this disease.
Supplementary material
Table S1 Polymerase chain reaction primers used for amplification of KAL1 exons 5, 6 and 9, their annealing temperature and product size
Acknowledgments
The authors thank all of the patients and the Endocrinology team from João de Barros Barreto University Hospital – UFPA and the Genetics team from the Laboratory of Human and Medical Genetics – UFPA. Financial support was received from UFPA(PROPESP)/FADESP and CAPES.
Disclosure
The authors have no conflicts of interest in this work.